The Decision Making System in the Program of Subsidized Pharmaceutical Provision

More than 20 years ago, the System of Health Technology Assessment was implemented in most European countries, the United States of America and Canada and it has been functioning ever since. There are, as well, some legislative acts regulating the rules for the formation of lists of medicinal drugs in Russia; however, a common decision-making system does not exist. Purpose: to study the decision-making system of including medicines onto the list of subsidized pharmaceutical provision. Content and methods: 250 specialists from the Ministry of Health, pharmaceutical and insurance companies, medical university staff and clinical physicians were surveyed anonymously. Results: comprehensive evaluation of decision-making system of medicines provision was obtained and prospects for improvement were determined.